About Balchem Corporation
https://www.balchem.comBalchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
CEO
Theodore Lee Harris
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2010-01-21 | Forward | 3:2 |
| 2007-01-22 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 199
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:4.9M
Value:$827.6M
BLACKROCK, INC.
Shares:4.84M
Value:$815.87M
VANGUARD GROUP INC
Shares:3.89M
Value:$657.01M
Summary
Showing Top 3 of 514
About Balchem Corporation
https://www.balchem.comBalchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets in the United States and internationally. It operates through three segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
Income Statement
| Period | Revenue | Operating Expense | Net Income | Net Profit Margin | Earnings Per Share | EBITDA |
|---|---|---|---|---|---|---|
| Q3-2025 | $267.56M ▲ | $40.87M ▼ | $40.29M ▲ | 15.06% ▲ | $1.25 ▲ | $76.81M ▲ |
| Q2-2025 | $255.47M ▲ | $41.67M ▲ | $38.28M ▲ | 14.98% ▲ | $1.18 ▲ | $63.18M ▲ |
| Q1-2025 | $250.52M ▲ | $37.15M ▼ | $37.05M ▲ | 14.79% ▲ | $1.14 ▲ | $61.88M ▲ |
| Q4-2024 | $240M ▲ | $38.89M ▲ | $33.58M ▼ | 13.99% ▼ | $1.03 ▼ | $58.2M ▼ |
| Q3-2024 | $239.94M | $37.37M | $33.84M | 14.1% | $1.04 | $58.87M |
Balance Statement
| Period | Cash & Short-term | Total Assets | Total Liabilities | Total Equity |
|---|---|---|---|---|
| Q3-2025 | $65.09M ▼ | $1.66B ▼ | $363.17M ▼ | $1.3B ▲ |
| Q2-2025 | $65.43M ▲ | $1.68B ▲ | $410.33M ▲ | $1.27B ▲ |
| Q1-2025 | $49.9M ▲ | $1.62B ▲ | $408.85M ▼ | $1.21B ▲ |
| Q4-2024 | $49.52M ▼ | $1.58B ▼ | $425.46M ▲ | $1.15B ▼ |
| Q3-2024 | $73.69M | $1.6B | $419.72M | $1.18B |
Cash Flow Statement
| Period | Net Income | Cash From Operations | Cash From Investing | Cash From Financing | Net Change | Free Cash Flow |
|---|---|---|---|---|---|---|
| Q3-2025 | $40.29M ▲ | $65.57M ▲ | $-14.94M ▼ | $-50.83M ▼ | $-334K ▼ | $50.67M ▲ |
| Q2-2025 | $38.28M ▲ | $47.25M ▲ | $-6.62M ▼ | $-28.76M ▲ | $15.53M ▲ | $40.44M ▲ |
| Q1-2025 | $37.05M ▲ | $36.46M ▼ | $-5.91M ▲ | $-31.97M ▲ | $386K ▲ | $30.9M ▼ |
| Q4-2024 | $33.58M ▼ | $52.32M ▲ | $-36.96M ▼ | $-35.21M ▼ | $-24.18M ▼ | $39.59M ▼ |
| Q3-2024 | $33.84M | $51.3M | $-9.18M | $-34.39M | $9.96M | $42.15M |
Revenue by Products
| Product | Q4-2024 | Q1-2025 | Q2-2025 | Q3-2025 |
|---|---|---|---|---|
 Product Sales | $240.00M ▲ | $250.00M ▲ | $260.00M ▲ | $270.00M ▲ |
 Royalty | $0 ▲ | $0 ▲ | $0 ▲ | $0 ▲ |
Revenue by Geography
| Region | Q4-2024 | Q2-2025 | Q3-2025 | Q1-2025 |
|---|---|---|---|---|
 NonUS | $60.00M ▲ | $70.00M ▲ | $70.00M ▲ | $60.00M ▼ |
 UNITED STATES | $180.00M ▲ | $190.00M ▲ | $200.00M ▲ | $190.00M ▼ |
CEO
Theodore Lee Harris
Compensation Summary
(Year 2024)
Split Record
| Date | Type | Ratio |
|---|---|---|
| 2010-01-21 | Forward | 3:2 |
| 2007-01-22 | Forward | 3:2 |
ETFs Holding This Stock
Summary
Showing Top 3 of 199
Ratings Snapshot
Rating : B
Most Recent Analyst Grades
Grade Summary
Showing Top 1 of 1
Price Target
Institutional Ownership
BLACKROCK INC.
Shares:4.9M
Value:$827.6M
BLACKROCK, INC.
Shares:4.84M
Value:$815.87M
VANGUARD GROUP INC
Shares:3.89M
Value:$657.01M
Summary
Showing Top 3 of 514